Viewing Study NCT00602459


Ignite Creation Date: 2025-12-24 @ 3:00 PM
Ignite Modification Date: 2025-12-26 @ 10:52 AM
Study NCT ID: NCT00602459
Status: COMPLETED
Last Update Posted: 2023-05-22
First Post: 2008-01-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Sponsor: National Cancer Institute (NCI)
Organization: